Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

12.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.0K
Pleiotropy01:33

Pleiotropy

37.8K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
37.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Increasing Community Access to Testing, Treatment, and Response Program - A Model for Future Public Health Emergency Response.

NEJM catalyst innovations in care delivery·2026
Same author

Suprachoroidal Triamcinolone Injection for the Management of Chronic Uveitis-Associated Ocular Hypotony.

Case reports in ophthalmological medicine·2026
Same author

Rare-Variant Burden across Lysosomal Genes Implicates Sialylation and Ganglioside Metabolism in Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

The GBA1 p.E427K (p.E388K) Variant Is a Risk Factor for Synucleinopathies: A Meta-Analysis.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Genetic associations between post-traumatic stress disorder and REM-sleep behavior disorder.

NPJ Parkinson's disease·2026
Same author

The use of virtual reality in forensic-correctional psychiatric settings: A systematic review.

Psychiatry and clinical neurosciences·2026

Related Experiment Video

Updated: May 9, 2025

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

3.5K

Genome-Wide Association Study of Glucocerebrosidase Activity Modifiers.

Emma N Somerville1,2, Lynne Krohn1,2, Konstantin Senkevich1,3

  • 1The Neuro (Montréal Neurological Institute-Hospital), McGill University, Montréal, QC, Canada.

Molecular Neurobiology
|April 29, 2025
PubMed
Summary

Genetic variants in GBA1 are linked to Parkinson's disease (PD) risk. This study identifies novel genetic associations with glucocerebrosidase (GCase) activity, potentially revealing new therapeutic targets for PD.

Keywords:
GBA1Genome-wide association studyGlucocerebrosidaseLysosomal metabolismParkinson’s disease

More Related Videos

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

8.0K
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

18.9K

Related Experiment Videos

Last Updated: May 9, 2025

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

3.5K
In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

8.0K
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

18.9K

Area of Science:

  • Genetics
  • Neuroscience
  • Biochemistry

Background:

  • Variants in the GBA1 gene, encoding glucocerebrosidase (GCase), are a common genetic risk factor for Parkinson's disease (PD).
  • GCase deficiency is linked to increased PD risk, but other genetic factors may also modify this risk.
  • Understanding genetic modifiers of GCase activity is crucial for elucidating PD pathogenesis.

Purpose of the Study:

  • To identify common genetic variants associated with GCase activity.
  • To replicate previously reported associations between GBA1 variants and GCase activity.
  • To explore potential interactions between GCase and other enzymes in the context of PD.

Main Methods:

  • Genome-wide association study (GWAS) performed on two independent cohorts: Columbia University (697 PD cases, 347 controls) and Parkinson's Progression Markers Initiative (PPMI) (357 PD cases, 163 controls).
  • Analysis included replication of known GBA1 associations and identification of novel loci.
  • Interaction analyses were conducted to investigate potential functional relationships between enzymes.

Main Results:

  • GBA1 variants, notably N370S, showed the strongest association with decreased GCase activity.
  • A novel association was identified in the GAA locus, encoding acid alpha-glucosidase, with potential interaction with GCase.
  • Several PD-risk loci were found to be potentially associated with GCase activity.

Conclusions:

  • GBA1 variants are confirmed as major determinants of GCase activity.
  • A novel genetic association implicates acid alpha-glucosidase in modulating GCase activity, suggesting a potential interaction relevant to PD.
  • Further research is warranted to validate these findings and elucidate the functional mechanisms linking acid alpha-glucosidase and GCase in Parkinson's disease.